WebSep 2, 2024 · 总体而言,ETNA-VTE Europe研究显示了欧洲各地临床医生处方艾多沙班的实际临床情况,较随机对照试验更具贴近临床实践;这项研究的从真实世界的视角对Hokusai VTE研究结果进行了补充,将艾多沙班的主要疗效和安全性数据扩展到实际的临床环境中;结 … WebFeb 27, 2014 · The primary objective is to demonstrate the non-inferiority of edoxaban (preceded by a short course of LMWH) compared with dalteparin for the prevention of the combined outcome of recurrent venous thromboembolism (VTE) or major bleeding in subjects with VTE associated with cancer during a 12-month study period.
Hokusai-VTE_百度文库
http://www.cem.org.cn/rhtml/20160804/index.htm Web开馆时间:周一至周日7:00-22:30 周五 7:00-12:00; 我的图书馆 totocs802
Hokusai-VTE study suggests certain sub-groups EurekAlert!
WebSep 4, 2013 · hokusai-vte对急性vte noacs治疗大样本随机对照试验计划作了总结。研究共纳入27000多名病人,几乎是15年前低分子量肝素试验所纳入人数的4倍。这些试验是成功 … WebAug 4, 2016 · accp10专家组针对新型口服抗凝药物治疗vte原始文献以及荟萃分析认为:⑴达比加群、利伐沙班、阿哌沙班、依度沙班降低vte复发风险疗效与vka相似,包括合并恶性肿瘤患者;⑵合并恶性肿瘤患者,低分子肝素抗凝治疗降低血栓栓塞症复发风险疗效优于vka;⑶研究 ... WebDec 30, 2013 · Venous thromboembolism is associated with a high morbidity and, if left untreated, may progress to fatal outcome. The standard treatment of venous thromboembolism consists of heparin followed by long-term treatment with a vitamin K antagonist. ... This review discusses the Hokusai-VTE study with special emphasis on … toto cs80